Send us Feedback

Amylin Pharmaceuticals (AMLN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 30-JUN
2011		 30-SEP
2011		 31-DEC
2011		 31-MAR
2012		 30-JUN
2012
Cash & Equivalents 444M 461M 215M 315M 106M
Short Term Investments 0 0 0 0 233M
Accounts Receivable 47.8M 50.9M 45.5M 52.8M 61.2M
Inventories 103M 107M 112M 136M 144M
Pre-paid Expenses 0 0 0 0 17.1M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 35.5M 40.0M 49.2M 57.6M 9.95M
Total Current Assets 630M 659M 421M 561M 571M
Property, Plant & Equipment 818M 825M 831M 830M 822M
Goodwill & Intangibles 0 0 602M 594M 258M
Other Long-term Assets 35.5M 32.4M 16.3M 22.6M 348M
Total Long-Term Assets 853M 858M 1.45B 1.45B 1.43B
Total Assets 1.48B 1.52B 1.87B 2.01B 2.00B
Accounts Payable 0 0 0 0 32.1M
Accrued Expenses 0 0 0 0 0
Short Term Debt 0 0 0 0 98.8M
Other Current Liabilities 200M 242M 296M 290M 45.3M
Total Current Liabilities 200M 242M 296M 290M 308M
Long Term Debt 647M 654M 1.42B 659M 1.64B
Capital Lease Obligations 0 0 0 947M 41.0M
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 319M 308M 293M 103M 47.5M
Total Long-term Liabilities 966M 962M 1.71B 1.71B 1.73B
Minority Interest 0 0 0 0 0
Total Liabilities 1.17B 1.20B 2.01B 2.00B 2.04B
Preferred Stock 0 0 0 0 0
Common Par 0 0 0 0 164K
Additional Paid-In Capital 0 0 0 0 2.77B
Retained Earnings 0 0 0 0 -2.82B
Treasury Stock 0 0 0 0 0
Other Equity 317M 312M -139M 8.29M 10.0K
Total Shareholder's Equity 317M 312M -139M 8.29M -42.4M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki